|
Name: Prazepam
Type: Benzodiazepine
AKA: Centrax
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Prazepam, a benzodiazepine, was developed in the 1970s. It is used for its anxiolytic effects and is studied for its efficacy in treating anxiety and related disorders.
|
|
V. Legal Information
Prazepam, a benzodiazepine, is classified as a Schedule IV controlled substance in the US, allowing limited medical use. It is similarly regulated in many countries due to its potential for abuse and dependency. The UNODC and other regulatory bodies emphasize the need for balanced regulation to ensure safe medical use while preventing misuse. Trends indicate ongoing control measures to monitor and regulate benzodiazepines.
US Federal Schedule - IV
Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are: Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Prazepam is a benzodiazepine used to treat anxiety. It causes sedation, reduced heart rate, and impaired motor function. Short-term use is effective for anxiety management, but long-term use can lead to dependence, cognitive impairment, and significant health issues. Overdose risks include severe sedation, respiratory depression, and potential death. Safe use involves following prescribed dosages. Recent research explores its efficacy in treating anxiety and highlights associated risks.  |
|
VII. Psychological Effects
Prazepam, a benzodiazepine, enhances GABA-A receptor activity, providing anxiolytic and sedative effects. Immediate effects include relaxation and improved mood, lasting several hours. Long-term use may lead to cognitive impairments, dependence, and mood disturbances. Research highlights the risks of cognitive decline and psychological dependence with prolonged use.
 |
|
VIII. Culture
Prazepam, a benzodiazepine used for anxiety, has been used medicinally since the mid-20th century. It has no significant cultural lore or historical mentions outside of medical literature. It is widely used in Western countries for its anxiolytic effects. Modern discussions focus on the benefits and risks of benzodiazepines, including dependency and cognitive impairment. Its cultural impact includes debates over the use of anxiolytics in mental health treatment. Proponents highlight its effectiveness for anxiety, while opponents warn of the potential for misuse and long-term cognitive effects.
 |